Status:
COMPLETED
Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
Bacterial Infection
Intensive Care
Eligibility:
All Genders
18-105 years
Phase:
NA
Brief Summary
The delayed administration of an adequate antimicrobial therapy is a strong predictor of impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis Campaign guidelines...
Eligibility Criteria
Inclusion
- • Suspected or proven bacterial infection at emergency department triage
Exclusion
- Imminent death
- Pregnancy
- Breast-feeding
- For patients managed by a medicalized pre-hospital emergency team before ED admission : administration of a first dose of antimicrobial agent before ED admission
- Lack of coverage by the public health insurance system
- Patient's refusal for study enrollment
- Lack of confirmed bacterial infection (i.e., documented either clinically, microbiologically or by imaging procedures) in patients with a suspected bacterial infection at emergency departement triage
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2018
Estimated Enrollment :
780 Patients enrolled
Trial Details
Trial ID
NCT03299894
Start Date
October 12 2017
End Date
June 10 2018
Last Update
August 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Hospital center of Orleans
Orléans, France, 45067